Sequoia China leads $7m seed round for Cambridge-based biotech firm RootPath

Sequoia China leads $7m seed round for Cambridge-based biotech firm RootPath

Neil Shen, managing partner of Sequoia Capital China. Photographer: Jason Alden/Bloomberg

RootPath, a Cambridge-based biotechnology company, has announced the closing of a $7 million seed funding round led by Sequoia China.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter